CRONYXIN Injection

Страна: ПАР

мова: англійська

Джерело: South African Health Products Regulatory Authority (SAHPRA)

Доступна з:

Afrivet Business Management (Pty) Ltd

Дозування:

See ingredients

Фармацевтична форма:

Injection

Склад:

Each 1.0 ml Liquid contains FLUNIXIN MEGLUMINE A equivalent to FLUNIXIN 50.0 mg

Терапевтична области:

C 0206. NON-NARCOTIC ANALGESICS. ANTIPYRETICS

Статус Авторизація:

Registered

Дата Авторизація:

2002-06-08

Характеристики продукта

Afrivet Business Management (Pty) Ltd CRONYXIN Each ml contains 50 mg
flunixin
Page 1 of 3 _ Package Insert _ CRONYXIN INJECTION
VETERINARY MEDICINE
SCHEDULING STATUS S3
PROPRIETARY NAME (AND DOSAGE FORM)
CRONYXIN INJECTION solution for injection
COMPOSITION
Each ml contains:
Flunixin meglumine equivalent to 50 mg flunixin
Preservative: phenol 0.5 % m/v
Antioxidant at time of manufacture: sodium formaldehyde sulfoxylate
0.22 % m/v
PHARMACOLOGICAL CLASSIFICATION
C.2.6 non-narcotic analgesics, antipyretics
PHARMACOLOGICAL ACTION
Flunixin meglumine is a non- steroidal analgesic with
anti-inflammatory and anti-pyretic
properties.
It acts by interfering with the arachidonic acid pathway of
prostaglandin synthesis.
INDICATIONS
CATTLE:_ _The control of acute inflammation associated with
respiratory disease. Prophylaxis in
acute bovine pulmonary emphysema and oedema. Adjuvant therapy in the
treatment of
acute mastitis.
HORSES:_ _Alleviation of inflammation and pain associated with
musculoskeletal disorders.
Alleviation of visceral pain associated with colic.
CONTRA – INDICATIONS
Use is contra-indicated in animals suffering from cardiac, hepatic or
renal disease, where
there is a possibility of gastro-intestinal ulceration or bleeding and
where there is evidence of
blood dyscrasia.
Not to be used in animals known to be hypersensitive to the active
ingredient.
Avoid use in dehydrated hypovolemic or hypotensive animals as there is
a potential risk of
increased renal toxicity.
WARNINGS
Do not exceed the recommended dose or treat animals for more than 5
consecutive days.
WITHDRAWAL PERIODS:
Milk from lactating cows should be discarded during treatment and may
only be taken for
human consumption during treatment.
Animals may not be slaughtered for human consumption during treatment.
Animals may be slaughtered for human consumption only after 7 days
from the last
treatment.
DOSAGE AND DIRECTIONS FOR USE
Avoid intra-arterial injection.
CATTLE: The recommended dose is 2 ml CRONYXIN INJECTION per 45 kg
bodyweight
(equivalent to